Inventor
GREGORY A. MCCLELLAND
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,102,637Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis202412,083,227Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis202411,311,532High dosage valbenazine formulation and compositions, methods, and kits related thereto2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to NEUROCRINE BIOSCIENCES INC (3)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to ABBVIE INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 3 | 2022–2024 |
| ABBVIE INC | 2 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2024 |